• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

Medical News Interviews

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Eicosapentaenoic Acid: Prevention of Coronary Artery Disease

0
  • by alexperjescuadmin
  • in AHA 2005 · Cardiovascular
  • — 17 Nov, 2005
Eicosapentaenoic Acid: Prevention of Coronary Artery Disease
AudioMedica News
Eicosapentaenoic Acid: Prevention of Coronary Artery Disease
Eicosapentaenoic Acid: Prevention of Coronary Artery Disease
00:00 /
RSS Feed
Share
Link
Embed

A 20 000-person study of eicosapentaenoic acid supplements gave solid scientific support for EPA use to prevent cardiovascular events among patients with established coronary artery disease. Mitsuhiro Yokoyama of Kobe University told us more about it.
[audio:https://www.audiomedica.com/podcasting/aha2005/Mitsuhiro_Yokoyama.mp3]

Click here for all the interviews from AHA 2005

Share

Tags: diseasepatient

You may also like...

  • Aggressive Statins: the IDEAL Treatment Aggressive Statins: the IDEAL Treatment 17 Nov, 2005
  • BNP Test: Key Diagnostic Step for Heart Failure (PEP Study) BNP Test: Key Diagnostic Step for Heart Failure (PEP Study) 3 Sep, 2007
  • Statins and ARBs: a Special Combination? Statins and ARBs: a Special Combination? 17 Nov, 2005
  • Eptifibatide as Effective as Abciximab in Primary PCI for Acute ST Elevation Myocardial Infarction: EVA-AMI Study Eptifibatide as Effective as Abciximab in Primary PCI for Acute ST Elevation Myocardial Infarction: EVA-AMI Study 6 Nov, 2007

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Warfarin Trumps Platelet Agents in Atrial Fibrilation
  • Next story Aggressive Statins: the IDEAL Treatment
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic…
    • Microbiome Diversity Key To Survival After…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • Esophageal Cancer Prevented By Proton Pump Inhibitor…
    • Brachytherapy “Excellent” After Breast…
  • Home
  • Cardiovascular
  • AHA 2005
  • Eicosapentaenoic Acid: Prevention of Coronary Artery Disease

© Copyright 2021 AudioMedica.com. Typegrid Theme by WPBandit.